ALTERED CARDIOVASCULAR RESPONSIVENESS TO ADRENOCEPTOR AGONISTS IN ENDURANCE-TRAINED MEN

被引:14
作者
SVEDENHAG, J
MARTINSSON, A
EKBLOM, B
HJEMDAHL, P
机构
[1] KAROLINSKA INST, DEPT PHYSIOL 3, S-10401 STOCKHOLM 60, SWEDEN
[2] KAROLINSKA INST, DEPT PHARMACOL, S-10401 STOCKHOLM 60, SWEDEN
[3] KAROLINSKA HOSP, DEPT CLIN PHARMACOL, S-10401 STOCKHOLM 60, SWEDEN
关键词
ADRENERGIC RECEPTORS; HUMAN SUBJECTS; BLOOD PRESSURES; HEART RATE; CARDIAC CONTRACTILITY; PHYSICAL CONDITIONING;
D O I
10.1152/jappl.1991.70.2.531
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The influence of physical training on responses to intravenous infusions of phenylephrine (Phe) and isoproterenol (Iso) were investigated in 10 well-trained runners (WT) and 10 age-matched untrained controls (UT). The latter were reinvestigated after a 4-mo training period. The venous plasma Iso and Phe concentrations attained during infusions were lower in WT than in UT. Responses were related to the corresponding plasma concentrations. Phe-induced decreases and Iso-induced increases in heart rate were less pronounced (P < 0.01) in WT than in UT. At venous plasma concentrations of 100 nM Phe and 0.8 nM Iso, the responses were -9 +/- 1 and 30 +/- 2, and -17 +/- 2 and 44 +/- 4 beats/min, respectively. Increases in blood pressures during Phe infusions were greater in WT than in UT (100 nM Phe: systolic 36 +/- 3 vs. 25 +/- 3 mmHg, P < 0.05). The Iso-induced decrease in diastolic blood pressure was also more pronounced in WT (0.8 nM Iso: -29 +/- 3 vs. -15 +/- 2 mmHg, P < 0.01). Iso-induced changes in systolic time intervals showed no consistent differences between training states. Increases in plasma adenosine 3',5'-cyclic monophosphate during Iso infusions were smaller (P < 0.05) in WT than in UT, whereas increases in plasma glycerol were larger (P < 0.05). Lymphocyte beta-2-adrenoceptor function and binding characteristics did not differ between training states. In summary, the present results indicate that beta-adrenergic vasodilator and alpha-adrenergic vasopressor responses are enhanced in endurance-trained subjects. However, other indexes of adrenoceptor responsiveness could be increased, unchanged, or decreased in well-trained subjects, depending on the response studied. This may be due to differentiated (i.e., not generalized) changes in adrenoceptor function and/or to changes in vascularization and baroreceptor function.
引用
收藏
页码:531 / 538
页数:8
相关论文
共 33 条
  • [1] REFLEX VAGAL WITHDRAWAL AND THE HEMODYNAMIC-RESPONSE TO INTRAVENOUS ISOPROTERENOL IN THE PRESENCE OF BETA-ANTAGONISTS
    ARNOLD, JMO
    MCDEVITT, DG
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (02) : 199 - 208
  • [2] EFFECTS OF THE BETA-2-ADRENOCEPTOR ANTAGONIST ICI-118,551 ON EXERCISE TACHYCARDIA AND ISOPRENALINE-INDUCED BETA-ADRENOCEPTOR RESPONSES IN MAN
    ARNOLD, JMO
    OCONNOR, PC
    RIDDELL, JG
    HARRON, DWG
    SHANKS, RG
    MCDEVITT, DG
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (05) : 619 - 630
  • [3] HUMAN-HEART BETA-ADRENOCEPTORS - A FAIR COMPARISON WITH LYMPHOCYTE BETA-ADRENOCEPTORS
    BRODDE, OE
    BECKERINGH, JJ
    MICHEL, MC
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (10) : 403 - 407
  • [4] DIFFERENTIATION OF BETA-1-ADRENOCEPTOR AND BETA-2-ADRENOCEPTOR-MEDIATED EFFECTS IN HUMANS
    BRODDE, OE
    DAUL, A
    WELLSTEIN, A
    PALM, D
    MICHEL, MC
    BECKERINGH, JJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (02): : H199 - H206
  • [5] BROWN BL, 1972, ADV CYCL NUCL RES<D>, V2, P25
  • [6] SYMPATHETIC NERVOUS ACTIVITY DURING EXERCISE
    CHRISTENSEN, NJ
    GALBO, H
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1983, 45 : 139 - 153
  • [7] CRYER PE, 1980, NEW ENGL J MED, V303, P436
  • [8] LEVEL OF PHYSICAL-FITNESS AND ADIPOCYTE LIPOLYSIS IN HUMANS
    DESPRES, JP
    BOUCHARD, C
    SAVARD, R
    TREMBLAY, A
    MARCOTTE, M
    THERIAULT, G
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1984, 56 (05) : 1157 - 1161
  • [9] SENSITIVITY OF THE PHYSIOLOGICALLY HYPERTROPHIED HEART TO ISOPROTERENOL
    DICKHUTH, HH
    THEISSEN, M
    LEHMANN, M
    AUCHSCHWELK, W
    KEUL, J
    [J]. INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1987, 8 (06) : 392 - 396
  • [10] HIMMSHAGEN J, 1967, PHARMACOL REV, V19, P367